TREA

78668046 - MTM LABORATORIES

Follow

Information

  • Trademark
  • 78668046
  • Serial Number
    78668046
  • Registration Number
    3290364
  • Filing Date
    July 12, 2005
    19 years ago
  • Registration Date
    September 11, 2007
    17 years ago
  • Transaction Date
    May 27, 2014
    10 years ago
  • Status Date
    April 18, 2014
    10 years ago
  • Published for Opposition Date
    June 26, 2007
    17 years ago
  • Location Date
    September 11, 2007
    17 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BENJAMIN, SARA NICOLE
  • Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
MTM LABORATORIES
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: "LABORATORIES"
  • GS0011: Diagnostic preparations, reagents and chemical test kits for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use
  • GS0051: Pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits, comprising of medical diagnostic reagents and assays, for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations namely in-vitro and in-vivo diagnostic test kits, comprising of medical diagnostic reagents and assays, diagnostic liquid-immuno-assay kits, comprising of medical diagnostic reagents and assays, diagnostic solid-phase immuno-assay kits, comprising of medical diagnostic reagents and assays, diagnostic strip-tests, comprising of medical diagnostic reagents and assays, diagnostic dip-stick-tests, comprising of medical diagnostic reagents and assays, point of care tests, comprising of medical diagnostic reagents and assays, diagnostic lateral-flow assay kits, comprising of medical diagnostic reagents and assays, diagnostic flow-through assay kits, comprising of medical diagnostic reagents and assays, diagnostic immuno-chromatographic kits, comprising of medical diagnostic reagents and assays; diagnostic equipment namely medical diagnostic test strips for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases, cotton, wood, and plastic sticks, cotton swabs and tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; therapeutic compounds and substances, namely, vaccines for prevention and treatment of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases
  • GS0091: Diagnostic equipment, namely, plates having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; diagnostic equipment, namely, chromatography columns and clothing for use in laboratories for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases
  • GS0101: Point-of-care testing machines, namely, for immunochemistry testing, medical diagnostic liquid-immuno-assay machines, medical diagnostic solid-phase immuno assay machines, medical diagnostic ELISA testing machines, medical diagnostic immuno-chromatographic machines; diagnostic equipment, namely containers for medical samples, vessels, namely, containers specially designed for storing and transporting medical samples, test tubes, namely, for medical samples and medical diagnostic testing, brushes, namely, for sampling of medical samples from body cavities and epithelia, medical syringes, needles for medical use, spatulas, namely, for medical samples and medical diagnostic testing, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases
  • GS0421: Scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceuticals, chemistry, medical diagnostics and food technology; pharmaceutical research services, chemical research services and medical diagnostic research services for clinical, therapeutic, prophylactic and medical diagnostic applications and procedures; research and development of pharmaceutical products and substances for others; providing information on the subject of scientific research in the field of biochemistry, disease related molecular markers and molecular diagnostics; chemical, biological, molecular biology and pharmacogenomic analysis services
  • GS0441: Medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds
Case File Event Statements
  • 4/18/2014 - 10 years ago
    28 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 3/24/2014 - 10 years ago
    27 - WITHDRAWAL OF ATTORNEY GRANTED Type: WOAG
  • 3/24/2014 - 10 years ago
    26 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED Type: WOAR
  • 4/20/2012 - 12 years ago
    25 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 4/20/2012 - 12 years ago
    24 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 4/18/2012 - 12 years ago
    23 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/11/2007 - 17 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/26/2007 - 17 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/6/2007 - 17 years ago
    20 - NOTICE OF PUBLICATION Type: NPUB
  • 4/23/2007 - 17 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/18/2007 - 17 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/17/2007 - 17 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/17/2007 - 17 years ago
    16 - ASSIGNED TO LIE Type: ALIE
  • 4/16/2007 - 17 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/16/2007 - 17 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/22/2007 - 17 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/21/2007 - 17 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/21/2007 - 17 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/21/2006 - 17 years ago
    10 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/21/2006 - 17 years ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/31/2006 - 18 years ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/7/2006 - 18 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/7/2006 - 18 years ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/4/2006 - 18 years ago
    5 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/15/2006 - 18 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/15/2006 - 18 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/1/2006 - 18 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/18/2005 - 19 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP